XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.1
INVESTMENTS (Details Narrative)
$ / shares in Units, ¥ in Millions
3 Months Ended 9 Months Ended
Jan. 30, 2022
Jan. 18, 2022
$ / shares
shares
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2023
CNY (¥)
Dec. 31, 2022
USD ($)
Aug. 31, 2021
USD ($)
Aug. 31, 2021
CNY (¥)
Income loss from equity method investemnts         $ (20,932) $ (156,235)        
Three Shares Transfer Agreements [Member]                    
Percentage of issued and outstanding equity interest   51.00%                
Stock issued during period, shares | shares   700,551                
Stock issued price per share | $ / shares   $ 8                
Co-operation Agreement [Member]                    
Agreement description The term of the Cooperation Agreement shall be three (3) years commencing from January 30, 2022. In accordance with the Cooperation Agreement, WJM shall be entitled to 30% of the net income generated by the Joint Project while the Company shall be entitled to 70% of the net income thereof and bear 100% of the net losses of the Joint Project                  
Guangyuan [Member]                    
Income loss from equity method investemnts       16,153        
Yushe Pharmaceutical [Member] | Guangyuan [Member]                    
Equity method investments     $ 300,000   $ 300,000   ¥ 2.0      
Equity method investment ownership percentage     20.00%   20.00%   20.00%      
Gaojing Private Fund [Member]                    
Equity method investments               $ 700,000 $ 700,000 ¥ 4.8
Equity method investment ownership percentage                 32.00% 32.00%
Income loss from equity method investemnts     $ 14,711 $ 49,247 $ 20,932 $ 140,082